Multimodal fluorescence-mediated tomography and SPECT/CT for small-animal imaging.
Multimodal fluorescence-mediated tomography and SPECT/CT for small-animal imaging.
复制标题
DOI:
10.2967/jnumed.112.105742
复制
发表时间:
2013-04
期刊:
影响因子:
--
通讯作者:
Culver JP
中科院分区:
文献类型:
--
作者:
Solomon M;Nothdruft RE;Akers W;Edwards WB;Liang K;Xu B;Suddlow GP;Deghani H;Tai YC;Eggebrecht AT;Achilefu S;Culver JP
Spatial and temporal co-registration of nuclear and optical images would enable the fusion of the information from theses complementary molecular imaging modalities. A critical challenge in integration is fitting optical hardware into the nuclear imaging platforms. Flexible fiber-based fluorescence mediated tomography (FMT) systems provide a viable solution because the various imaging bore sizes of small animal nuclear imaging systems can potentially accommodate the FMT fiber imaging arrays. Further, FMT imaging facilitates co-registering the nuclear and optical contrasts in time. Herein, we combine a fiber based FMT system with a preclinical NanoSPECT/CT platform. Feasibility of in vivo imaging is demonstrated by tracking the accumulation of a monomolecular multimodal imaging agent (MOMIA) in a sentinel lymph node (SLN) of a rat. The fiber-based, video-rate FMT imaging system is composed of 12 alternating sources (785nm and 830nm LDs) and 13 detectors. To maintain high temporal sampling, the system simultaneously acquires ratio-metric data at each detector. The data is reconstructed using the normalized Born approach with a three-dimensional finite element model derived from an anatomical CT image of a rat for accurate light propagation modeling. Nuclear and optical contrasts are integrated by using a MOMIA. Data collection begins immediately after injection of the MOMIA intradermally into the forepaw with the FMT data acquired simultaneously with both the SPECT and CT. Fluorescence and radioactivity from the MOMIA were co-localized in a spatially coincident region. Intravital imaging with surgical exposure of the lymph node validated the localization of the optical contrast. The optical and nuclear contrasts where integrated by incorporating SPECT as a prior in the DOT reconstruction. The feasibility of integrating a fiber-based, video-rate FMT system with a commercial preclinical NanoSPECT/CT platform was established. The co-localization of the MOMIA in a spatially coincident region on the co-registered FMT-SPECT-CT image may facilitate the development of the next generation preclinical and clinical multimodal optical-nuclear platform for a broad array of imaging applications. Due to the complementary information provided by the SPECT, CT and FMT imaging, this approach has potential to elucidate the underlying biological processes relevant to cancer diagnosis and therapy monitoring.